Tess Lamer

1.1k total citations
18 papers, 624 citations indexed

About

Tess Lamer is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Tess Lamer has authored 18 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Tess Lamer's work include SARS-CoV-2 and COVID-19 Research (8 papers), Computational Drug Discovery Methods (3 papers) and Peptidase Inhibition and Analysis (3 papers). Tess Lamer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Computational Drug Discovery Methods (3 papers) and Peptidase Inhibition and Analysis (3 papers). Tess Lamer collaborates with scholars based in Canada, Poland and France. Tess Lamer's co-authors include John C. Vederas, Conrad Fischer, Howard S. Young, M. Joanne Lemieux, Elena Arutyunova, Marco J. van Belkum, Muhammad Bashir Khan, Wayne Vuong, D. Lorne Tyrrell and Michael Joyce and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Tess Lamer

15 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tess Lamer Canada 9 353 339 212 116 55 18 624
Arif Ali China 13 297 0.8× 257 0.8× 404 1.9× 46 0.4× 39 0.7× 24 747
Lalitha Guruprasad India 14 233 0.7× 116 0.3× 263 1.2× 84 0.7× 38 0.7× 43 624
Carolina Q. Sacramento Brazil 16 438 1.2× 119 0.4× 318 1.5× 156 1.3× 30 0.5× 34 920
Francesca Alessandra Ambrosio Italy 15 175 0.5× 125 0.4× 360 1.7× 120 1.0× 77 1.4× 38 697
Kristina Lanko Netherlands 9 300 0.8× 233 0.7× 216 1.0× 133 1.1× 10 0.2× 14 589
Justin Shields Canada 9 353 1.0× 288 0.8× 252 1.2× 107 0.9× 20 0.4× 12 743
Carina Stiller Germany 6 363 1.0× 119 0.4× 232 1.1× 43 0.4× 73 1.3× 9 643
Muhammad Junaid China 18 236 0.7× 173 0.5× 512 2.4× 35 0.3× 33 0.6× 34 760
Joseph T. Ortega United States 13 319 0.9× 140 0.4× 300 1.4× 53 0.5× 16 0.3× 29 715
Qingxing Wang China 5 306 0.9× 142 0.4× 165 0.8× 44 0.4× 23 0.4× 8 540

Countries citing papers authored by Tess Lamer

Since Specialization
Citations

This map shows the geographic impact of Tess Lamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tess Lamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tess Lamer more than expected).

Fields of papers citing papers by Tess Lamer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tess Lamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tess Lamer. The network helps show where Tess Lamer may publish in the future.

Co-authorship network of co-authors of Tess Lamer

This figure shows the co-authorship network connecting the top 25 collaborators of Tess Lamer. A scholar is included among the top collaborators of Tess Lamer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tess Lamer. Tess Lamer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lamer, Tess, et al.. (2025). Structure and inhibition of diaminopimelic acid epimerase by slow‐binding α‐methyl amino acids. Protein Science. 34(5). e70139–e70139.
2.
Lamer, Tess, Tamara Aleksandrzak‐Piekarczyk, Ryan T. McKay, et al.. (2025). Solution Structure of the Broad-Spectrum Bacteriocin Garvicin Q. International Journal of Molecular Sciences. 26(16). 7846–7846.
3.
Fischer, Conrad, Marco J. van Belkum, Tess Lamer, et al.. (2024). Assessment of optimized FRET substrates as universal corona- and picornavirus main protease substrates for screening assays. RSC Advances. 14(48). 35438–35446.
4.
Lamer, Tess, Pu Chen, Michelle Venter, et al.. (2024). Discovery, characterization, and structure of a cofactor-independent histidine racemase from the oral pathogen Fusobacterium nucleatum. Journal of Biological Chemistry. 300(11). 107896–107896. 1 indexed citations
5.
Chen, Pu, Elena Arutyunova, Conrad Fischer, et al.. (2024). A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (Mpro) of SARS-CoV-2 and MERS-CoV. SHILAP Revista de lepidopterología. 4(8). 3217–3227. 6 indexed citations
6.
Lamer, Tess & John C. Vederas. (2023). Simplified cloning and isolation of peptides from “sandwiched” SUMO-peptide-intein fusion proteins. BMC Biotechnology. 23(1). 11–11. 7 indexed citations
7.
Belkum, Marco J. van, Tamara Aleksandrzak‐Piekarczyk, Tess Lamer, & John C. Vederas. (2023). Lactococcus lactis mutants resistant to lactococcin A and garvicin Q reveal missense mutations in the sugar transport domain of the mannose phosphotransferase system. Microbiology Spectrum. 12(1). e0313023–e0313023. 5 indexed citations
8.
Arutyunova, Elena, Jimmy Lu, Muhammad Bashir Khan, et al.. (2023). SARS-CoV-2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. ACS Central Science. 9(4). 696–708. 31 indexed citations
9.
Arutyunova, Elena, Pu Chen, Muhammad Bashir Khan, et al.. (2023). The Effect of Deuteration and Homologation of the Lactam Ring of Nirmatrelvir on Its Biochemical Properties and Oxidative Metabolism. SHILAP Revista de lepidopterología. 3(6). 528–541. 3 indexed citations
10.
Lu, Jimmy, Muhammad Bashir Khan, Elena Arutyunova, et al.. (2022). Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition. Frontiers in Chemistry. 10. 852210–852210. 25 indexed citations
11.
12.
Lamer, Tess, Marco J. van Belkum, & John C. Vederas. (2022). Methods for Recombinant Production and Purification of Peptides as SUMO‐Peptide‐Intein Fusion Proteins to Protect from Degradation. Current Protocols. 2(10). e571–e571. 4 indexed citations
13.
Arutyunova, Elena, Muhammad Bashir Khan, Conrad Fischer, et al.. (2021). N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer. Journal of Molecular Biology. 433(13). 167003–167003. 33 indexed citations
14.
Vuong, Wayne, Conrad Fischer, Muhammad Bashir Khan, et al.. (2021). Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies. European Journal of Medicinal Chemistry. 222. 113584–113584. 65 indexed citations
15.
Bai, Bing, Elena Arutyunova, Muhammad Bashir Khan, et al.. (2021). Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors. RSC Medicinal Chemistry. 12(10). 1722–1730. 37 indexed citations
16.
Vuong, Wayne, Muhammad Bashir Khan, Conrad Fischer, et al.. (2020). Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nature Communications. 11(1). 4282–4282. 340 indexed citations
17.
Fischer, Conrad, Tess Lamer, Mahmoud Gheblawi, et al.. (2020). Optimizing PEG-Extended Apelin Analogues as Cardioprotective Drug Leads: Importance of the KFRR Motif and Aromatic Head Group for Improved Physiological Activity. Journal of Medicinal Chemistry. 63(20). 12073–12082. 14 indexed citations
18.
Fischer, Conrad, Tess Lamer, Wang Wang, et al.. (2019). Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents. European Journal of Medicinal Chemistry. 166. 119–124. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arif Ali Breakdown of academic impact, for papers by Lalitha Guruprasad Breakdown of academic impact, for papers by Carolina Q. Sacramento Breakdown of academic impact, for papers by Francesca Alessandra Ambrosio Breakdown of academic impact, for papers by Kristina Lanko Breakdown of academic impact, for papers by Justin Shields Breakdown of academic impact, for papers by Carina Stiller Breakdown of academic impact, for papers by Muhammad Junaid Breakdown of academic impact, for papers by Joseph T. Ortega Breakdown of academic impact, for papers by Qingxing Wang
Rankless by CCL
2026